Fellowship Call for 2019
October 12, 2018ICAT One Health Study Day Registration
February 29, 2024Full NameProfessor Carel LeRoux
Diabetes Complications Research Centre
University College Dublin
Webpage:www.ucd.ie
Email Address:Email hidden; Javascript is required.
- physiology and non-communicable disease
- cancer/oncology
- neuroscience and mental health
- Medicine
- Surgery
- Obstetrics and Gynaecology
- Pathology
- Sports and Exercise Medicine
- Cardiology
- Endocrinology
- Gastroenterology
- Nephrology
- Oncology
- Physiology
We are interested in how the gut talks to the brain to impact on intentional and unintentional weight loss. We are also interested in how intentional weight loss can be used to improve the complications of obesity including diabetes, diabetic kidney disease, obesity related cancers, cardiovascular disease and infertility. These questions have resulted in high impact papers that helped change clinical care pathways:
le Roux CW, et al. 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial. Lancet. 2017 Apr 8;389(10077):1399-1409.
Miras AD, le Roux CW. Metabolic Surgery in a Pill. Cell Metab. 2017 May 2;25(5):985-987.
Pi-Sunyer X, le Roux CW et al. A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. N Engl J Med. 2015 Jul 2;373(1):11-22.
Elliott J, le Roux CW et al. Gut Hormone Suppression Increases Food Intake After Esophagectomy With Gastric Conduit Reconstruction. Ann Surg. 2015 Nov;262(5):824-29.